Financial Daily from THE HINDU group of publications
Saturday, May 06, 2006

Cross Currency

Group Sites

Markets - Stocks
Columns - Ear to the ground

Dabur Pharma gains on value buying

The Re 1-face valued Dabur Pharma stock, has been gaining steadily since April 1, with moderate volumes these days, thanks to investors who are said to be finally latching on to it after the company was carved out of FMCG major Dabur.

Dabur Pharma, in which IFC Washington holds over 7 per cent, is now believed to be coming up on its own. It closed at Rs 61.80 on the NSE, a level that is marginally lower than its recent high of over Rs 65.

Nilanjan Dey

More Stories on : Stocks | Ear to the ground | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Capstocks to host workshop

NFO collections: MFs not yet fully invested
Graphite India attracts interest
Reliance Comm to sponsor secondary market GDRs/ADRs
Navin Fluorine, Guj Fluorochem fall as carbon credit price slumps
Dabur Pharma gains on value buying
AK Capital: Up on broking foray talk
Uncertain movement
Markets end flat; mixed action seen
Air Deccan to raise Rs 400 cr
Reliance Petro IPO allotment completed
Plethico Pharma lists at 36% premium
Lokesh debuts with 75 pc premium

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line